Applications of 1,3,4,5-Tetrahydro-2H-1-Benzazepin-2-One in Industrial Manufacturing

As a dedicated manufacturer, we supply 1,3,4,5-Tetrahydro-2H-1-Benzazepin-2-One (also referred to in industry literature as "benzazepinone core") for specialized applications in high-value downstream sectors. Our technical team supports auditable traceability from upstream synthesis through to integration in end-use solutions where performance, consistency, and compliance take priority. Below, discover targeted deployment across differentiated manufacturing segments based on authentic global industry data and customer process feedback.

1. Cardiovascular Pharmaceutical Intermediates

This benzazepinone derivative acts as a crucial building block for the manufacture of antihypertensive and antiarrhythmic APIs, particularly as a structural precursor in the synthesis of calcium channel blockers. It enters downstream processes via precise condensation and cyclization steps, ensuring consistent provision of core moieties necessary to support therapeutic efficacy in regulated drug formulations. Our facility maintains rigorous production records to support validated GMP-compliant supply.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia Monographs for intermediates
• US FDA cGMP (21 CFR Parts 210/211) for API production
• China GMP 2020 Revision

Typical usage ratio

• 5%–20% w/w in multi-step synthesis, optimized according to target API yield, with validated stoichiometry in route development documentation.

Downstream process integration

• Introduced at the core ring-building stage during condensation reactions; serves as the initiator for further functionalization, nitration, or alkylation steps in batch and continuous syntheses.

Final product types

• Antihypertensive drugs (e.g., benidipine, manidipine)
• Antiarrhythmic agents
• Finished oral solid doses and injectable formulations produced by pharmaceutical manufacturers

2. CNS Active Pharmaceutical Ingredient Synthesis

Downstream producers use this intermediate within the production pipeline for certain central nervous system (CNS) modulators, including anxiolytics and antipsychotic medications. Our customers report direct benefits from consistently low impurity content and batch-to-batch identity in multistage transformations. This enables reliable process control during integrations involving Buchwald–Hartwig couplings and Grignard reactions.

Industry compliance standards

• FDA Guidance for Industry: Quality Considerations in Demonstrating Biosimilarity
• EU EudraLex Volume 4: GMP for Intermediates
• Japan JP18 Pharmacopoeia (when used in Japanese pipeline synthesis)
• Qualified Person oversight for API synthesis in the EU

Typical usage ratio

• 8%–25% of initial charge, adjusted based on specific target molecule and reaction yield requirements; controlled by data-recorded molar conversion rates.

Downstream process integration

• Employed in the stepwise construction of CNS-active compounds, introduced following base ring formation; participates directly in nucleophilic substitution or amide formation.

Final product types

• Anxiolytic and antipsychotic APIs
• Pregabalin analogues
• Proprietary CNS modulator intermediates

3. Specialty Fine Chemical Synthesis for Custom Research

Synthetic chemistry CROs and research institutions utilize this benzazepinone as a structural platform for development of novel heterocyclic compounds. Research-grade batches are favored for their narrow impurity profiles and consistent nucleophilicity, supporting downstream innovation in targeted molecular design. Our technical documentation supports full auditing for research safety and compliance, streamlining project onboarding.

Industry compliance standards

• OECD GLP Principles for chemical test substances
• ISO 9001:2015 Quality systems for specialty chemical production
• REACH compliance (EU Regulation 1907/2006) for laboratory use
• Material safety data sheet (MSDS) provision per GHS

Typical usage ratio

• 0.5–10 mmol scale in initial research synthesis or as directed by client-supplied protocol; actual mass input determined by research design brief.

Downstream process integration

• Functioning as the substrate for substituted benzazepinone formation in laboratory synthesis, inserted following ring-opening or closed system modification steps.

Final product types

• Proprietary research intermediates
• Molecular probes
• Lead compound libraries for pharmaceutical screening

4. Agrochemical Intermediate Production

Agrochemical formulators incorporate benzazepinone derivatives in the downstream synthesis of crop protection actives where cyclic amide motifs impart selectivity and metabolic stability. Our production batches are specifically optimized to meet critical impurity thresholds for regulatory registration in global markets, and we routinely supply technical documentation for evaluation in pilot plant scale-up.

Industry compliance standards

• CROP LIFE International Stewardship for intermediates
• FAO/WHO Specifications for Plant Protection Products
• ISO 17025 Accredited laboratory analysis
• Relevant regional pesticide registration rules (e.g., US EPA 40 CFR 180; China GB 2763-2021 MRL)

Typical usage ratio

• 3%–12% w/w in active ingredient prototype synthesis, determined by laboratory scale validation and threshold impurity cut-off.

Downstream process integration

• Added at the key ring expansion or lactamization stage in process chemistry; its cyclic structure is tailored into new active scaffolds with targeted activity profiles for crop safety.

Final product types

• Precursor intermediates for herbicide and fungicide actives
• Final crop protection molecules after further derivatization
• Agrochemical actives submitted for field trial registration

5. Advanced Polymer Additive Synthesis

Producers of advanced engineering resins and specialty polymers integrate benzazepinone units to generate monomers with tailored ring structures, influencing properties such as high-temperature stability and impact resistance. Production uses rely on reliable molecular weight control, made possible by precise material specification and analytical conformity. This feedstock enters process lines before final polymerization, supporting production of specialty plastics for industrial and automotive use.

Industry compliance standards

• ISO 9001:2015 for batch traceability
• REACH (EU) Registration for monomer supply
• UL Yellow Card certification for polymer additives (as applicable)
• ROHS Directive 2011/65/EU for electronics sector plastics

Typical usage ratio

• 0.2%–2% by weight in precursor resin formulations; dosage adjusted based on targeted polymer performance, as determined by in-house compounding trials.

Downstream process integration

• Introduced at pre-polymerization or comonomer addition stages, contributing to backbone modification or crosslinking function in batch or continuous-flow polymerization systems.

Final product types

• High-performance engineering plastics
• Modified polyamide and polyimide resins
• Specialty composite prepregs for transport or electronics market